These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34647177)

  • 1. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
    Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
    Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy.
    Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X
    Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
    Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
    Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
    Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy.
    Lee HJ; Kim JM; Chin YJ; Chong GO; Park SH; Lee YH; Hong DG; Lee YS
    Anticancer Res; 2020 Jan; 40(1):451-458. PubMed ID: 31892600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
    Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
    Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
    Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Liu J; Tang G; Zhou Q; Kuang W
    Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
    Laliscia C; Gadducci A; Mattioni R; Orlandi F; Giusti S; Barcellini A; Gabelloni M; Morganti R; Neri E; Paiar F
    Tumori; 2022 Aug; 108(4):376-385. PubMed ID: 34235995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
    Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of outcome using pretreatment
    Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.